Modulation of glucagon actions by phorbol myristate acetate in isolated hepatocytes. Effect of hypothyroidism

J. Adolfo Garcái-Sáinz, Marina Macías-Silva, S. M.Teresa Hernández-Sotomayor, Ma Eugenia Torres-Márquez, Dev Trivedi, Victor J. Hruby

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Phorbol myristate acetate (PMA) inhibits glucagon-stimulated cyclic AMP accumulation and shifts to the right the dose-response curve to glucagon for ureagenesis. In cells from hypothyroid rats the effect of PMA on glucagon-stimulated ureagenesis was much more pronounced, but its effect on cyclic AMP accumulation was similar to that observed in the control cells. The stimulations of ureagenesis by the glucagon analogue THG and dibutyril cyclic AMP (But2-cAMP) were also diminished by PMA, to a greater extent in cells from hypothyroid rats than in those from euthyroid rats. PMA inhibited the increases in cytoplasmic [Ca2+] induced by glucagon. THG or But2-cAMP; the effect of PMA was much more marked in cells from hypothyroid rats than in the controls. Treatment of the cells with glucagon or THG increased the production of citrulline by subsequently isolated mitochondria, whereas PMA diminished their effects. The results suggest that PMA alter glucagon actions at least at two levels; (i) cyclic AMP production and (ii) elevation of cytosol calcium. The increased sensitivity to PMA of some glucagon effects in hypothyroid rat seems to be related to the latter action.

Original languageEnglish (US)
Pages (from-to)235-243
Number of pages9
JournalCellular Signalling
Issue number3
StatePublished - 1990


  • Glucagon
  • calcium
  • cyclic AMP
  • phorbol esters
  • protein kinase C
  • ureagenesis

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'Modulation of glucagon actions by phorbol myristate acetate in isolated hepatocytes. Effect of hypothyroidism'. Together they form a unique fingerprint.

Cite this